Jiangxi Fushine Pharmaceutical (300497.SZ): "Administration Permit for New Food Raw Material of Fusaprtoin Protein" Accepted for Review
Fushen Pharmaceutical Industry (300497.SZ) issued an announcement that its holding subsidiary, Jiangxi Fushen Biotechnology Co., Ltd...
Jiangxi Fushine Pharmaceutical (300497.SZ) announced recently that its controlling subsidiary, Jiangxi Fuxiang Biotechnology Co., Ltd. (hereinafter referred to as "Fuxiang Biotechnology"), has received the "Administrative License Application Acceptance Form for New Food Ingredients" (WeiShiXinShenZi [2025] No. 0010) issued by the National Health Commission (hereinafter referred to as "NHCC"). The NHCC has decided to accept the administrative license application for the knife mould protein proposed by Fuxiang Biotechnology in accordance with the provisions of the Administrative Licensing Law of the People's Republic of China.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
